Edition:
United Kingdom

CTI Biopharma Corp (CTIC.OQ)

CTIC.OQ on NASDAQ Stock Exchange Capital Market

2.26USD
18 Jul 2018
Change (% chg)

$-1.73 (-43.36%)
Prev Close
$3.99
Open
$3.00
Day's High
$3.00
Day's Low
$2.26
Volume
920,042
Avg. Vol
130,244
52-wk High
$5.36
52-wk Low
$2.26

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 10.48 -0.082
FY 2017 Dec '17 0.46 -0.332
Sep '17 1.71 -0.279
Jun '17 22.23 0.033
Mar '17 0.75 -0.707
FY 2016 Dec '16 9.14 -0.079
Sep '16 4.43 -1.042
Jun '16 7.36 -0.707
Mar '16 36.47 0.119
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.90 3.00 0.00 --
Quarter Ending Dec-18 4 0.93 3.00 0.00 --
Year Ending Dec-18 4 13.22 19.48 10.50 --
Year Ending Dec-19 4 18.08 22.00 10.70 --
Earnings (per share)
Quarter Ending Sep-18 4 -0.25 -0.20 -0.31 --
Quarter Ending Dec-18 4 -0.28 -0.19 -0.44 --
Year Ending Dec-18 4 -0.89 -0.71 -1.19 --
Year Ending Dec-19 4 -0.84 -0.80 -0.90 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.36 32.76
P/E High - Last 5 Yrs. -- 298.43 45.44
P/E Low - Last 5 Yrs. -- 91.46 24.26
Beta 0.62 0.93 0.89
Price to Sales (TTM) 3.86 112.59 5.73
Price to Book (MRQ) 3.24 15.55 5.47
Price to Tangible Book (MRQ) 3.16 14.65 7.05
Price to Cash Flow (TTM) -- 72.62 23.29
% Owned Institutions 42.95 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.36 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 201.93 408.16 8.01
Sales (TTM) vs TTM 1 Yr. Ago -34.88 79.91 5.64
Sales - 5 Yr. Growth Rate -- 32.07 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 104.65 29.00 20.60
EPS (TTM) vs TTM 1 Yr. Ago 51.54 -- --
EPS - 5 Yr. Growth Rate -- 39.51 10.66
Capital Spending - 5 Yr. Growth Rate -44.92 39.99 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.11 1.92 2.22
Current Ratio (MRQ) 2.15 5.49 3.03
LT Debt to Equity (MRQ) 15.71 34.93 12.51
Total Debt to Equity (MRQ) 34.58 36.74 16.84
Interest Coverage (TTM) -25.92 -101.19 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 96.61 39.30 54.37
Gross Margin - 5 Yr. Avg. -- 50.70 52.17
EBITD Margin (TTM) -129.97 -- --
EBITD - 5 Yr. Avg -230.04 -587.40 10.81
Operating Margin (TTM) -132.08 -734.14 4.57
Operating Margin - 5 Yr. Avg. -234.78 -609.01 6.23
Pre-Tax Margin (TTM) -138.13 -708.28 5.43
Pre-Tax Margin - 5 Yr. Avg. -245.54 -612.53 6.67
Net Profit Margin (TTM) -138.13 -709.68 1.72
Net Profit Margin - 5 Yr. Avg. -245.54 -615.55 2.94
Effective Tax Rate (TTM) -- 23.24 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 365,480 23,033,779 860,399,112
Net Income/Employee (TTM) -504,840 3,118,930 101,210,045
Receivable Turnover (TTM) 70.35 20.76 5.87
Inventory Turnover (TTM) 0.60 2.48 3.41
Asset Turnover (TTM) 0.40 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -54.88 0.26 11.14
Return on Assets - 5 Yr. Avg. -88.48 3.71 12.40
Return on Investment (TTM) -85.83 2.21 14.61
Return on Investment - 5 Yr. Avg. -137.13 2.88 16.14
Return on Equity (TTM) -127.14 3.85 16.34
Return on Equity - 5 Yr. Avg. -227.84 3.83 17.40
  1 Year 3 Year 5 Year
Sales % 256.20 18.29 --
EPS (TTM) % 71.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CTI Biopharma Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.55 -1.95 98 53
13 Week -0.30 -5.16 98 66
26 Week -20.39 -26.44 61 79
52 Week -17.11 -29.74 74 52
YTD -19.53 -29.33 55 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 63.79%
# of Holders: 92
Total Shares Held: 36,982,594
3 Mo. Net Change: 100,067
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 2
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.